The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Coagulation Controls Market Research Report 2025
Synopsis
This product is a calibrator for prothrombin time (PT) and fibrinogen (FIB) test items.
Global Coagulation Controls market is projected to reach US$ 12300 million in 2029, increasing from US$ 7970 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coagulation Controls market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Coagulation Controls market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Stago
Technoclone
Sekisui Medical
Yusen Bio
King Diagnostic
Sysmex
Randox
Siemens Healthineers
Excelen
Union Bio
Wondfo Biotech
Zonci
Liangchen
Jlang
Succeeder
Segment by Type
10 Vials/Box
12 Vials/Box
Segment by Application
Hospital
Research Institute
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Coagulation Controls report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
This product is a calibrator for prothrombin time (PT) and fibrinogen (FIB) test items.
Global Coagulation Controls market is projected to reach US$ 12300 million in 2029, increasing from US$ 7970 million in 2022, with the CAGR of 6.4% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Coagulation Controls market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Coagulation Controls market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Roche
Stago
Technoclone
Sekisui Medical
Yusen Bio
King Diagnostic
Sysmex
Randox
Siemens Healthineers
Excelen
Union Bio
Wondfo Biotech
Zonci
Liangchen
Jlang
Succeeder
Segment by Type
10 Vials/Box
12 Vials/Box
Segment by Application
Hospital
Research Institute
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Coagulation Controls report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Coagulation Controls Market Overview
1.1 Product Overview and Scope of Coagulation Controls
1.2 Coagulation Controls Segment by Type
1.2.1 Global Coagulation Controls Market Value Comparison by Type (2023-2029)
1.2.2 10 Vials/Box
1.2.3 12 Vials/Box
1.3 Coagulation Controls Segment by Application
1.3.1 Global Coagulation Controls Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Other
1.4 Global Coagulation Controls Market Size Estimates and Forecasts
1.4.1 Global Coagulation Controls Revenue 2018-2029
1.4.2 Global Coagulation Controls Sales 2018-2029
1.4.3 Global Coagulation Controls Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Coagulation Controls Market Competition by Manufacturers
2.1 Global Coagulation Controls Sales Market Share by Manufacturers (2018-2023)
2.2 Global Coagulation Controls Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Coagulation Controls Average Price by Manufacturers (2018-2023)
2.4 Global Coagulation Controls Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Coagulation Controls, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Coagulation Controls, Product Type & Application
2.7 Coagulation Controls Market Competitive Situation and Trends
2.7.1 Coagulation Controls Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Coagulation Controls Players Market Share by Revenue
2.7.3 Global Coagulation Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Coagulation Controls Retrospective Market Scenario by Region
3.1 Global Coagulation Controls Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Coagulation Controls Global Coagulation Controls Sales by Region: 2018-2029
3.2.1 Global Coagulation Controls Sales by Region: 2018-2023
3.2.2 Global Coagulation Controls Sales by Region: 2024-2029
3.3 Global Coagulation Controls Global Coagulation Controls Revenue by Region: 2018-2029
3.3.1 Global Coagulation Controls Revenue by Region: 2018-2023
3.3.2 Global Coagulation Controls Revenue by Region: 2024-2029
3.4 North America Coagulation Controls Market Facts & Figures by Country
3.4.1 North America Coagulation Controls Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Coagulation Controls Sales by Country (2018-2029)
3.4.3 North America Coagulation Controls Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Coagulation Controls Market Facts & Figures by Country
3.5.1 Europe Coagulation Controls Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Coagulation Controls Sales by Country (2018-2029)
3.5.3 Europe Coagulation Controls Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Coagulation Controls Market Facts & Figures by Country
3.6.1 Asia Pacific Coagulation Controls Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Coagulation Controls Sales by Country (2018-2029)
3.6.3 Asia Pacific Coagulation Controls Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Coagulation Controls Market Facts & Figures by Country
3.7.1 Latin America Coagulation Controls Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Coagulation Controls Sales by Country (2018-2029)
3.7.3 Latin America Coagulation Controls Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Coagulation Controls Market Facts & Figures by Country
3.8.1 Middle East and Africa Coagulation Controls Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Coagulation Controls Sales by Country (2018-2029)
3.8.3 Middle East and Africa Coagulation Controls Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Coagulation Controls Sales by Type (2018-2029)
4.1.1 Global Coagulation Controls Sales by Type (2018-2023)
4.1.2 Global Coagulation Controls Sales by Type (2024-2029)
4.1.3 Global Coagulation Controls Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Controls Revenue by Type (2018-2029)
4.2.1 Global Coagulation Controls Revenue by Type (2018-2023)
4.2.2 Global Coagulation Controls Revenue by Type (2024-2029)
4.2.3 Global Coagulation Controls Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Controls Price by Type (2018-2029)
5 Segment by Application
5.1 Global Coagulation Controls Sales by Application (2018-2029)
5.1.1 Global Coagulation Controls Sales by Application (2018-2023)
5.1.2 Global Coagulation Controls Sales by Application (2024-2029)
5.1.3 Global Coagulation Controls Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Controls Revenue by Application (2018-2029)
5.2.1 Global Coagulation Controls Revenue by Application (2018-2023)
5.2.2 Global Coagulation Controls Revenue by Application (2024-2029)
5.2.3 Global Coagulation Controls Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Controls Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Roche Coagulation Controls Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Stago
6.2.1 Stago Corporation Information
6.2.2 Stago Description and Business Overview
6.2.3 Stago Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Stago Coagulation Controls Product Portfolio
6.2.5 Stago Recent Developments/Updates
6.3 Technoclone
6.3.1 Technoclone Corporation Information
6.3.2 Technoclone Description and Business Overview
6.3.3 Technoclone Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Technoclone Coagulation Controls Product Portfolio
6.3.5 Technoclone Recent Developments/Updates
6.4 Sekisui Medical
6.4.1 Sekisui Medical Corporation Information
6.4.2 Sekisui Medical Description and Business Overview
6.4.3 Sekisui Medical Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sekisui Medical Coagulation Controls Product Portfolio
6.4.5 Sekisui Medical Recent Developments/Updates
6.5 Yusen Bio
6.5.1 Yusen Bio Corporation Information
6.5.2 Yusen Bio Description and Business Overview
6.5.3 Yusen Bio Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Yusen Bio Coagulation Controls Product Portfolio
6.5.5 Yusen Bio Recent Developments/Updates
6.6 King Diagnostic
6.6.1 King Diagnostic Corporation Information
6.6.2 King Diagnostic Description and Business Overview
6.6.3 King Diagnostic Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.6.4 King Diagnostic Coagulation Controls Product Portfolio
6.6.5 King Diagnostic Recent Developments/Updates
6.7 Sysmex
6.6.1 Sysmex Corporation Information
6.6.2 Sysmex Description and Business Overview
6.6.3 Sysmex Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sysmex Coagulation Controls Product Portfolio
6.7.5 Sysmex Recent Developments/Updates
6.8 Randox
6.8.1 Randox Corporation Information
6.8.2 Randox Description and Business Overview
6.8.3 Randox Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Randox Coagulation Controls Product Portfolio
6.8.5 Randox Recent Developments/Updates
6.9 Siemens Healthineers
6.9.1 Siemens Healthineers Corporation Information
6.9.2 Siemens Healthineers Description and Business Overview
6.9.3 Siemens Healthineers Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Siemens Healthineers Coagulation Controls Product Portfolio
6.9.5 Siemens Healthineers Recent Developments/Updates
6.10 Excelen
6.10.1 Excelen Corporation Information
6.10.2 Excelen Description and Business Overview
6.10.3 Excelen Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Excelen Coagulation Controls Product Portfolio
6.10.5 Excelen Recent Developments/Updates
6.11 Union Bio
6.11.1 Union Bio Corporation Information
6.11.2 Union Bio Coagulation Controls Description and Business Overview
6.11.3 Union Bio Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Union Bio Coagulation Controls Product Portfolio
6.11.5 Union Bio Recent Developments/Updates
6.12 Wondfo Biotech
6.12.1 Wondfo Biotech Corporation Information
6.12.2 Wondfo Biotech Coagulation Controls Description and Business Overview
6.12.3 Wondfo Biotech Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Wondfo Biotech Coagulation Controls Product Portfolio
6.12.5 Wondfo Biotech Recent Developments/Updates
6.13 Zonci
6.13.1 Zonci Corporation Information
6.13.2 Zonci Coagulation Controls Description and Business Overview
6.13.3 Zonci Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Zonci Coagulation Controls Product Portfolio
6.13.5 Zonci Recent Developments/Updates
6.14 Liangchen
6.14.1 Liangchen Corporation Information
6.14.2 Liangchen Coagulation Controls Description and Business Overview
6.14.3 Liangchen Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Liangchen Coagulation Controls Product Portfolio
6.14.5 Liangchen Recent Developments/Updates
6.15 Jlang
6.15.1 Jlang Corporation Information
6.15.2 Jlang Coagulation Controls Description and Business Overview
6.15.3 Jlang Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jlang Coagulation Controls Product Portfolio
6.15.5 Jlang Recent Developments/Updates
6.16 Succeeder
6.16.1 Succeeder Corporation Information
6.16.2 Succeeder Coagulation Controls Description and Business Overview
6.16.3 Succeeder Coagulation Controls Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Succeeder Coagulation Controls Product Portfolio
6.16.5 Succeeder Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Coagulation Controls Industry Chain Analysis
7.2 Coagulation Controls Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Coagulation Controls Production Mode & Process
7.4 Coagulation Controls Sales and Marketing
7.4.1 Coagulation Controls Sales Channels
7.4.2 Coagulation Controls Distributors
7.5 Coagulation Controls Customers
8 Coagulation Controls Market Dynamics
8.1 Coagulation Controls Industry Trends
8.2 Coagulation Controls Market Drivers
8.3 Coagulation Controls Market Challenges
8.4 Coagulation Controls Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
